74 related articles for article (PubMed ID: 7286841)
1. [Effect of Craviten on blood dopamine beta-hydroxylase activity].
Grabowska M; Gumińska M; Eckstein M
Folia Med Cracov; 1980; 22(3-4):359-66. PubMed ID: 7286841
[No Abstract] [Full Text] [Related]
2. Antiarrhythmic efficiency of Craviten and changes in the activities of serum dopamine beta-hydroxylase and erythrocyte membrane ATPases.
Gumińska M; Król W; Grabowska M; Grodecki J; Kawecka-Jaszcz K
Cor Vasa; 1986; 28(5):350-5. PubMed ID: 3024906
[TBL] [Abstract][Full Text] [Related]
3. Effect of butobendin on dopamine beta-hydroxylase in vitro.
Grabowska M; Gumińska M
Pol J Pharmacol; 1996; 48(1):39-45. PubMed ID: 9112626
[TBL] [Abstract][Full Text] [Related]
4. The influence of a new antiarrhythmic drug, Craviten (M-71) on coronary flow.
Banaszkiewicz W; Chodera A
Pol J Pharmacol Pharm; 1980; 32(6):849-53. PubMed ID: 6787574
[TBL] [Abstract][Full Text] [Related]
5. Central action of Craviten (M-71).
Maj J; Sowińska H; Baran L; Mogilnicka E; Przewłocka B
Pol J Pharmacol Pharm; 1980; 32(6):823-32. PubMed ID: 7243679
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties of Craviten (M-71).
Maj J; Kulig D; Myśliwiec D; Bugielska Z; Tomsa E; Zaczyńska-Kostrakiewicz M
Pol J Pharmacol Pharm; 1980; 32(6):855-75. PubMed ID: 7243682
[TBL] [Abstract][Full Text] [Related]
7. The influence of a new antiarrhythmic drug, Craviten (M-71) on the circulatory system in cats.
Banaszkiewicz W; Chodera A
Pol J Pharmacol Pharm; 1980; 32(6):841-8. PubMed ID: 7243681
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic investigations of Craviten. IV. First-pass metabolism in rats.
Danek A; Witek J
Pol J Pharmacol Pharm; 1980; 32(6):949-53. PubMed ID: 7243692
[TBL] [Abstract][Full Text] [Related]
9. The effect of a new antiarrhythmic drug: Craviten (M-71) on the ATP level in heart muscle slices in vitro.
Gumińska M; Kedryna T; Marchut E; Eckstein M
Pol J Pharmacol Pharm; 1980; 32(6):877-82. PubMed ID: 7243683
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic investigations of Craviten. III. Tissue distribution and elimination in rats.
Danek A; Witek J
Pol J Pharmacol Pharm; 1980; 32(6):941-8. PubMed ID: 7243691
[TBL] [Abstract][Full Text] [Related]
11. An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.
DeLisi LE; Phelps BH; Wise CD; Apostoles PS; Bigelow L; Wyatt RJ
Biol Psychiatry; 1981 Sep; 16(9):873-8. PubMed ID: 6117334
[No Abstract] [Full Text] [Related]
12. [Alterations of blood dopamine-beta-hydroxylase activity in patients with intrahepatic portal hypertension].
Du RY
Zhonghua Wai Ke Za Zhi; 1982 Jul; 20(7):394-6. PubMed ID: 7172892
[No Abstract] [Full Text] [Related]
13. Alteration of blood dopamine-beta-hydroxylase activity in patients with intrahepatic portal hypertension.
Du RY; Wang XH; Huang CT; Chen J
Chin Med J (Engl); 1982 Oct; 95(10):737-40. PubMed ID: 6817977
[No Abstract] [Full Text] [Related]
14. The effect of fasting on plasma tryptophane and dopamine beta hydroxylase activity.
Kuhn E; Rysánek K; Spánková H; Brodan V
Act Nerv Super (Praha); 1978 Feb; 20(1):61-2. PubMed ID: 636780
[No Abstract] [Full Text] [Related]
15. [Plasma dopamine beta-hydroxylase activity in hypertension treated with adrenergic beta receptor blockaders].
Merkulova NK
Ter Arkh; 1981; 53(1):69-72. PubMed ID: 7221913
[No Abstract] [Full Text] [Related]
16. Reduced serum dopamine-beta-hydroxylase activity in paranoid schizophrenia.
Arató M; Bagdy G; Perényi A
Biol Psychiatry; 1982 Jul; 17(7):853-4. PubMed ID: 6126229
[No Abstract] [Full Text] [Related]
17. [Effect of lithium carbonate on serum dopamine beta-hydroxylase activity in endogenous depression].
Grabowska M; Gumińska M; Broszkiewicz E
Folia Med Cracov; 1980; 22(3-4):419-24. PubMed ID: 6793467
[No Abstract] [Full Text] [Related]
18. [The dopamine theory of schizophrenia: reduced serum dopamine beta hydroxylase activity in paranoid schizophrenia].
Lipcsey A
Orv Hetil; 1981 Feb; 122(8):483. PubMed ID: 7290692
[No Abstract] [Full Text] [Related]
19. Pharmacokinetic investigations of Craviten. II. Dose-dependent elimination kinetics in rats following rapid intravenous injection.
Danek A; Witek J
Pol J Pharmacol Pharm; 1980; 32(6):933-9. PubMed ID: 7243690
[TBL] [Abstract][Full Text] [Related]
20. [Plasma dopamine beta-hydroxylase activity in clinically healthy children].
Mello P; Stagni S; Gualandi S; Illuminati B; Guidi M; Corsini F
Boll Soc Ital Biol Sper; 1980 Aug; 56(15):1597-602. PubMed ID: 7459080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
